SmartPharma Campaign for Napo’s Mytesi Chosen as Best HIV-Related Awareness in Healthline HIV Influencer Honors 2017

www.healthline.com


SmartPharma to Commercialize Mytesi (crofelemer) with Napo Pharmaceuticals:

SmartPharma has entered into an agreement with Napo Pharmaceuticals to provide marketing services for Mytesi® (crofelemer).


Katie MacFarlane Appointed to Board of Directors of Cortex Pharmaceuticals

Read More


Industry Pharmacists Organization (IPhO) names Katie MacFarlane, PharmD to advisory board

www.industrypharmacist.org


SmartPharma becomes a sponsor and member of BioNJ

www.bionj.com

SmartPharma client news: Merger of Cerulean Pharma Inc.
with Dare Bioscience, Inc.

Dare Bioscience is a healthcare company developing innovative products for women’s reproductive health


SmartPharma Campaign for Napo’s Mytesi Chosen as Best HIV-Related Awareness in Healthline HIV Influencer Honors 2017

Campaign to raise awareness of the issue of HIV-related diarrheaNapo logo


SmartPharma Client News: Aerie Pharmaceuticals Announces
FDA Approval of Rhopressa

Aerie Pharmaceuticals Announces U.S. FDA Approval of Rhopressa® (netarsudil ophthalmic solution) 0.02% for the Lowering of Elevated Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension.


Aerie Pharmaceuticals Announces FDA Approval of Rhopressa

Read More


Merger of Cerulean Pharma Inc. with Dare Bioscience, Inc.

Read More


Enteris Biopharma signs oral diabetes pact with Sanofi

http://www.fiercebiotech.com


Agile Therapeutics Announces Allowance of Several Patents on Novel Dosing Regimens for Its Pipeline of Follow-On Contraceptive Products

Read More


Sprout Pharmaceuticals to be Acquired by Valeant

Read More


Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial

Read More


Shire to Acquire NPS Pharma as Further Step in Building a Leading Biotech

Read More